Open in interactive viewer → charts, metric popovers & call review

REFI Is a Mortgage REIT Arguing, With Its Own Stock Chart, That It Should Stop Being One

Chicago Atlantic's Q3 makes the merger case in arithmetic — 14.8% yields, 0.48x leverage, a portfolio that profits from Fed hikes — and then quietly admits the growth engine has run out of cash.
REFI · Earnings Call · 2026-11-10

The tell is in the tape, not the transcript

Peter Sack spent the opening of REFI's third-quarter call doing something unusual for an earnings call: arguing with his own shareholders' valuation. He laid out a portfolio with an unlevered weighted average yield of roughly 14.8% against "approximately 6% to 8% on a comparable basis among select commercial mortgage REIT peers," running at 0.48x debt to equity versus a peer range of 3x to 5x, holding no RMBS, no CMBS, no agency paper, and originating nearly everything itself. Then the punchline: "Year-to-date through November 6, 2026, REFI and the VanEck Mortgage REIT Income ETF, ticker MORT, each generated total returns of approximately negative 17% to 18%."

Following the Fed's 25 basis point rate hike on September 17, the share prices of REFI and MORT both declined in line by about 9% through September 30, despite rising interest rates actually benefiting REFI's net interest income.

Peter Sack, Co-Chief Executive Officer · 2026-11-10
That is not rhetorical. The price tape shows REFI's 90-day peak at 2026-09-17 — 11.15 — and a 17% drawdown from it, with the stock down 13.7% over the window and 43.8% since inception. The peak is the hike date. This is a company whose earnings mechanically rise with the very variable that marks its stock down, and the market has decided it doesn't care. It's not an idiosyncratic story either: Fed rate hike was the third most prominent market-wide theme of the quarter, and rising interest rates is a genuinely new arrival in REFI's own keyword set — it did not rank in the prior eleven quarters of coverage. Management is now narrating a macro force they previously only alluded to. The mechanism is simple and worth stating plainly: roughly 57% of the book benefits from rate increases, there are no caps, and floors sit beneath the prime-based loans (73% of prime loans are currently at their floor). Every 25 basis points is worth about $0.015 per share of quarterly distributable earnings. The interest rate caps absence and the rate floors are the actual product design — convexity without a give-up on the way down.

A merger pitch wearing a quarterly-results costume

The company's own keyword ranking makes the subtext the text: Mortgage REIT is the quarter's number one theme, and it appears almost entirely in the context of explaining why REFI should not be compared to one. Alongside it sit special committee, proposed merger, merger agreement, and investor community. The special committee's stated constraints are blunt: subscale, a REIT election that limits the mandate, constrained access to institutional debt capital, and — the admission that matters — "our cannabis-only mandate has limited institutional investor participation in REFI common stock." A niche lender is conceding that its niche is the discount. What they will not concede is a strategy change. Asked whether the combined entity would pursue participation in syndicates or agency business to accelerate scale, Sack was flat: "I don't expect a broad shift into syndicates and certainly don't expect a broad shift into agency credits or mortgage-backed securities." The BDC wrapper is about the comparable set, not the assets. Be a BDC, get comped to private credit, and the 14.8% yield stops being invisible. The timing, though, has slipped and nobody was given a straight answer. Pablo Zuanic asked directly why the language went from late 2026 to early 2027 to simply "2027." Phil Silverman's reply was pure process: "At this point, that's the only public comment we can make on the rest of the process and that it's just -- it's ongoing as is customary." An N-14 that has been through two amendments since July and still awaits an SEC comment resolution is a year of limbo for a $237 million market-cap vehicle paying out nearly everything it earns.

The number the room walked past

Beneath the strategic argument sits a harder operational fact, delivered in David Kite's prepared remarks and never revisited in Q&A: "we have approximately $15.2 million available on the senior credit facility and total liquidity net of estimated liabilities and anticipated fundings of approximately $12 million... we expect originations to slow during the fourth quarter of 2026." That is a growth lender announcing it is out of runway. The $85.1 million of gross fundings sound impressive until you separate them: $62.6 million was the Koach notes share exchange, $22.5 million was actual lending, and only $5 million went to existing borrowers. The bank syndicate added just $7.5 million of capacity in the quarter. The pipeline, management conceded, declined — partly because they funded so much of it, partly because they can't fund the rest. Contrast that with March, when Sack described the same tension as a solvable one: "as our capital becomes constrained relative to the opportunity set, you obviously will see a forced change in selection and a forced change in the opportunities that we can fund." At the time there was $50 million of liquidity against a $616 million pipeline. Now the constraint is binding and the selection is being forced for them. The filed numbers already lean this way. The last 10-Q (Q2, since the filing lags the call) shows net interest income of $13 million, down 11% year on year, interest expense climbing to $2 million, +17% sequentially, and liabilities at 34.7% of assets, up 2.8pp year on year and a cumulative 10pp over three years. Equity has drifted from $310 million to $302 million, mechanically depressed by the Koach shares being netted inside stockholders' equity rather than shown as assets — a 3% year-on-year decline that management insists reverses as notes are repaid. GAAP net interest income of $12.5 million understates reality by roughly a fifth; adjusted for Koach cash interest it was $15.1 million. At 7.8x earnings, the market isn't paying for the accounting nuance either.

What quietly vanished

The most telling absences are lexical. A year ago the entire call ran through cannabis: license moats, 280E tax liabilities treated as leverage, interstate commerce insulation, diversified retail EBITDA. "Cannabis operator" was REFI's single highest-momentum keyword as recently as last quarter. This quarter it does not appear in the top 30 at all. Nor does the multi-quarter obsession with competitive dynamics — the repeated assurance, stated again as recently as March, that "we have not seen new lenders enter the market." There is no point defending a moat around a market you're leaving. What survives is the operational residue. The Koach thesis — sell properties at a low cap rate, recycle into higher ones, harvest exit fees — got its first proof point with the Florida sale, roughly $900,000 of fee income and an annualized return above 18% on a 12% stated yield. Sack was careful not to promise a cadence. And on the November 3 elections he found the one genuinely forward-looking note of the call, naming Pennsylvania, Texas and Georgia as medical markets likely to expand under new Democratic governors — an opportunity he explicitly said would accrue "for both REFI and LIEN." That last phrase is the honest framing. This quarter was not really about Q3. It was a 45-minute exhibit in a proxy fight, filed simultaneously with the earnings release, arguing that a differentiated asset base inside a discredited wrapper is worth more outside it. The arithmetic is compelling. The liquidity statement is the reason it's urgent.